Clinical Trial Update: A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and microbiology of C16G2 varnish for dental caries has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Caries

Drugs mentioned

• C16G2 varnish (C16G2 varnish)

Snippet

Sponsor: Armata Pharmaceuticals, Inc. | Conditions: Dental Caries | Phase 2 | Status: COMPLETED | Results posted: 2022-12-29